A polymorphism (rs2073287) of glutamate receptor, metabotropic 1 (GRM1) is associated with an increased risk of stroke in Korean population

  • Hyun-Kyung Park
  • Su Kang Kim
  • Sung Hoon Lim
  • Woo Yong Ahn
  • Geum-hee Gwak
  • Dae Jean JoEmail author
Original Paper


Glutamate toxicity plays a key role in neuronal cell death. The aim of this study was to investigate whether three single nucleotide polymorphisms (SNPs) (rs2073287, intron; rs2942, Lys931Lys; rs6923492, Ser993Pro) of glutamate receptor, metabotropic 1 (GRM1) were associated with the development and clinical features of stroke. We recruited 365 control subjects and 195 stroke patients consisted of 119 ischemic stroke (IS) and 76 intracerebral hemorrhage (ICH). All stroke patients were divided into clinical subgroups according to the scores of the National Institutes of Health Stroke Survey (NIHSS, < 6 and ≥ 6) and Modified Barthel Index (MBI, < 60 and ≥60). SNPStats and SPSS 18.0 were conducted to evaluate odds ratios (ORs), 95% confidence intervals (CIs), and P values. Multiple logistic regression models were performed to analyze the genetic data. A rs2073287 SNP of GRM1 was associated with the susceptibility of stroke (IS+ ICH) (P=0.002, OR=1.49, 95% CI=1.16-1.92 in allele frequencies). The rs2073287 was also associated with the development of IS (P=0.028, OR=1.40, 95% CI= 1.04-1.89 in allele frequencies) and ICH (P=0.006, OR=1.65, 95% CI=1.16–2.35 in allele frequencies). The G allele frequencies of rs2073287 in stroke (IS+ ICH), IS, and ICH were higher than in the control group, respectively. The rs2942 and rs6923492 were not related to stroke (IS+ICH), IS, and ICH, respectively. These results suggested that the G allele of rs2073287 could be a risk factor to the susceptibility of stroke in Korean population.


Glutamate receptor Metabotropic 1(GRM1) MBI NIHSS Polymorphism Stroke 


  1. 1.
    Arundine, M. & Tymianski, M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61:657–668 (2004).PubMedCrossRefGoogle Scholar
  2. 2.
    Hazell, A. S. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int 50:941–953 (2007).PubMedCrossRefGoogle Scholar
  3. 3.
    Doble, A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81:163–221 (1999).PubMedCrossRefGoogle Scholar
  4. 4.
    Hollmann, M. & Heinemann, S. Cloned glutamate receptors. Annu Rev Neurosci 17:31–108 (1994).PubMedCrossRefGoogle Scholar
  5. 5.
    Suzuki, M. et al. Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex. Eur J Neurosci 24:645–653 (2006).PubMedCrossRefGoogle Scholar
  6. 6.
    Wang, Y. & Qin, Z. H. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15: 1382–1402 (2010).PubMedCrossRefGoogle Scholar
  7. 7.
    Frauli, M. et al. Among the twenty classical L-amino acids, only glutamate directly activates metabotropic glutamate receptors. Neuropharmacology 50:245–253 (2006).PubMedCrossRefGoogle Scholar
  8. 8.
    Knopfel, T. & Uusisaari, M. Modulation of excitation by metabotropic glutamate receptors. Results Probl Cell Differ 44:163–175 (2008).PubMedCrossRefGoogle Scholar
  9. 9.
    Anwyl, R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Brain Res Rev 29:83–120 (1999).PubMedCrossRefGoogle Scholar
  10. 10.
    Lan, J. Y. et al. Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking. J Neurosci 21:6058–6068 (2001).PubMedGoogle Scholar
  11. 11.
    Pin, J. P. & Acher, F. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr Drug Targets CNS Neurol Disord 1: 297–317 (2002).PubMedCrossRefGoogle Scholar
  12. 12.
    Grysiewicz, R. A., Thomas, K. & Pandey, D. K. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 26:871–895, vii (2008).PubMedCrossRefGoogle Scholar
  13. 13.
    Wolf, P. A., Belanger, A. J. & D’Agostino, R. B. Management of risk factors. Neurol Clin 10:177–191 (1992).PubMedGoogle Scholar
  14. 14.
    Ikram, M. A. et al. Genomewide association studies of stroke. N Engl J Med 360:1718–1728 (2009).PubMedCrossRefGoogle Scholar
  15. 15.
    Lanktree, M. B., Dichgans, M. & Hegele, R. A. Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41:825–832 (2010).PubMedCrossRefGoogle Scholar
  16. 16.
    Somarajan, B. I., Kalita, J., Mittal, B. & Misra, U. K. Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population. J Neurol Sci 304:67–70 (2010).CrossRefGoogle Scholar
  17. 17.
    Tao, H. M. et al. TGF-beta1 869T/C polymorphism and ischemic stroke: sex difference in Chinese. Can J Neurol Sci 37:803–807 (2010).PubMedGoogle Scholar
  18. 18.
    Collin, T., Franconville, R., Ehrlich, B. E. & Llano, I. Activation of metabotropic glutamate receptors induces periodic burst firing and concomitant cytosolic Ca2+ oscillations in cerebellar interneurons. J Neurosci 29: 9281–9291 (2009).PubMedCrossRefGoogle Scholar
  19. 19.
    Aiba, A. et al. Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice. Cell 79:365–375 (1994).PubMedCrossRefGoogle Scholar
  20. 20.
    Conquet, F. et al. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature 372:237–243 (1994).PubMedCrossRefGoogle Scholar
  21. 21.
    Ichise, T. et al. mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination. Science 288:1832–1835 (2000).PubMedCrossRefGoogle Scholar
  22. 22.
    Albasanz, J. L., Dalfo, E., Ferrer, I. & Martin, M. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer’s disease and dementia with Lewy bodies correlates with stage of Alzheimer’s-disease-related changes. Neurobiol Dis 20:685–693 (2005).PubMedCrossRefGoogle Scholar
  23. 23.
    Ortiz, P. et al. Genetic analysis of the GRM1 gene in human melanoma susceptibility. Eur J Hum Genet 15:1176–1182 (2007).PubMedCrossRefGoogle Scholar
  24. 24.
    Baum, A. E. et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13:197–207 (2008).PubMedCrossRefGoogle Scholar
  25. 25.
    Shi, J. et al. Neurotransmission and bipolar disorder: a systematic family-based association study. Am J Med Genet B Neuropsychiatr Genet 147B:1270–1277 (2008).PubMedCrossRefGoogle Scholar
  26. 26.
    Caporaso, N. et al. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 4:e4653 (2009).PubMedCrossRefGoogle Scholar

Copyright information

© The Korean Society of Toxicogenomics and Toxicoproteomics and Springer Netherlands 2011

Authors and Affiliations

  • Hyun-Kyung Park
    • 1
  • Su Kang Kim
    • 2
  • Sung Hoon Lim
    • 3
  • Woo Yong Ahn
    • 4
  • Geum-hee Gwak
    • 4
  • Dae Jean Jo
    • 5
    Email author
  1. 1.Department of Emergency Medicine, School of MedicineKyung Hee UniversitySeoulKorea
  2. 2.Department of Pharmacology, School of MedicineKyung Hee UniversitySeoulKorea
  3. 3.Department of Medical Engineering, Graduate SchoolKyung Hee UniversitySeoulKorea
  4. 4.Department of Biochemistry and Molecular Biology, School of MedicineKyung Hee UniversitySeoulKorea
  5. 5.Department of Neurosurgery, School of MedicineKyung Hee UniversitySeoulKorea

Personalised recommendations